The Procter & Gamble Company (NYSE: PG): Corporate Profile & Financials
Source: The Procter & Gamble Company Form 10-K Fiscal Year Ended June 30, 2026
📋 Quick Facts: Company Snapshot
| Attribute | Disclosed Profile Detail |
|---|---|
| Official Corporate Name | The Procter & Gamble Company |
| Primary Stock Exchange | New York Stock Exchange |
| Stock Ticker Symbol | PG |
| Commission File Number | 1-434 |
| IRS Employer Identification Number | 31-0411980 |
| State of Incorporation | Ohio |
| Original Business Founding Date | 1837 |
| Corporate Incorporation History | Established in New Jersey in 1890; Incorporated in Ohio in 1905 |
| Corporate Headquarters | One Procter & Gamble Plaza, Cincinnati, Ohio 45202 |
| Corporate Telephone Contact | (513) 983-1100 |
| Chairman of the Board, President & CEO | Shailesh G. Jejurikar |
| Chief Financial Officer | Andre Schulten |
| Chief Legal Officer & Secretary | Susan Street Whaley |
| Independent Auditor | Deloitte & Touche LLP (serving continuously since 1890) |
| Total Employee Headcount | Approximately 104,000 (as of June 30, 2026) |
| Global Commercial Distribution Reach | Sold in about 180 countries and territories |
| On-the-Ground Operating Countries | Approximately 65 countries |
| Manufacturing Footprint | 96 sites globally (24 U.S. sites across 18 states; 72 international sites across 31 countries) |
| Total Common Shares Outstanding | 2,324,433,060 shares (as of July 31, 2026) |
| Total Common Stock Shareowners | Approximately 6 million shareowners (as of June 30, 2026) |
🏢 The Corporate Identity: Who They Are & Where They Came From
The Big Picture
The Procter & Gamble Company is a world-leading multinational consumer goods enterprise dedicated to providing branded products of superior quality, performance, and value. Operating within the fast-moving consumer packaged goods industry, the company manufactures and distributes products designed to serve daily-use consumer hygiene, cleaning, and personal care routines across roughly 180 countries and territories.
The company maintains on-the-ground operational facilities in approximately 65 countries, supporting a commercial model built on continuous product superiority across five critical commercial vectors: product performance, packaging design, brand communication, retail execution, and holistic value. P&G structures its global enterprise to deliver balanced top-line and bottom-line expansion while sustaining long-term operating cash flows.
- Operational Presence: Active manufacturing, distribution, and commercial operations span 65 countries, with product catalog delivery into about 180 countries and territories worldwide.
- Workforce Scale: An operational human capital footprint of approximately 104,000 employees as of June 30, 2026.
- Long-Term Value Equation: Sustainable growth underpinned by mid-to-high single-digit Core EPS expansion, organic sales growth exceeding addressable market growth, and adjusted free cash flow productivity of 90% or greater.
The Founders & Their Legacy
The enterprise traces its industrial lineage to a partnership formed in Cincinnati, Ohio, in 1837 by William Procter, an English candle maker, and James Gamble, an Irish soap maker. What originated as a local manufacturing venture producing basic household staples expanded over subsequent generations into a worldwide corporate organization centered around industrial research, chemical synthesis, and brand equity building.
The foundational principles established by its founders evolved into the modern Purpose, Values, and Principles (PVPs) governing P&G’s operating discipline. This cultural architecture emphasizes disciplined develop-from-within leadership progression, continuous consumer testing, strict compliance with statutory frameworks, and operational stewardship across worldwide production facilities.
The Journey: History & Evolution
Having initially operated as an informal partnership in Cincinnati, the company formalized its legal status when it was first established as a New Jersey corporation in 1890, followed by incorporation in Ohio in 1905. Through the twentieth and twenty-first centuries, the business transitioned from domestic soap and candle production into an international consumer packaged goods enterprise through organic brand creation and targeted acquisitions.
A transformative historical transaction included the 2005 acquisition of The Gillette Company, which established P&G’s worldwide franchise in grooming appliances and male and female wet shave systems. In recent years, management restructured its commercial architecture through focused portfolio optimization plans, divesting non-core operations, dissolving historical joint ventures, and liquidating positions in hyper-inflationary markets to reallocate capital into high-growth, daily-use segments.
- 1837: Partnership founded in Cincinnati, Ohio, by William Procter and James Gamble.
- 1890: Formal legal establishment as a New Jersey corporation.
- 1905: Incorporation in the State of Ohio.
- 2005: Strategic business combination through the acquisition of The Gillette Company.
- 2024–2025: Implementation and execution of limited market portfolio restructurings, culminating in the liquidation of operations in Argentina.
- 2026: Dissolution of the long-standing Glad joint venture with The Clorox Company, netting $476 million in fair value purchase proceeds.
The Corporate Umbrella
The Procter & Gamble Company functions as the ultimate corporate parent and legal registrant under SEC Commission File No. 1-434, operating through a network of domestic and international operating subsidiaries. Its global architecture integrates five Sector Business Units (SBUs) supported by regional Enterprise Markets (EMs), Global Business Services (GBS), and Corporate Functions (CF).
The SBUs maintain direct operational profit and loss accountability across major geographical markets designated as Focus Markets, while developing product upgrade pipelines, marketing strategies, and supply chain designs deployed by the Enterprise Markets across regional distribution channels.
⚙️ The Business Engine: What They Do & Where They Operate
The Core Divisions
The enterprise conducts its business through five reportable operating segments under U.S. GAAP: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. Corporate provides overall governance, treasury management, consolidated taxation adjustments, and houses incidental businesses managed at the corporate level.
Fabric & Home Care represents the largest segment, generating 35% of consolidated net sales and 35% of segment net earnings in fiscal 2026, followed by Baby, Feminine & Family Care at 24% of net sales and 24% of net earnings. Beauty delivers 19% of net sales and 17% of net earnings, Health Care comprises 14% of net sales and 15% of net earnings, and Grooming accounts for 8% of net sales and 9% of net earnings (excluding corporate reconciling items).
| Reportable Business Segment | Fiscal 2026 Net Sales ($ millions) | Share of Total Sales | Fiscal 2026 Net Earnings ($ millions) | Share of Segment Earnings (1) | Cost of Products Sold ($ millions) | SG&A Expense ($ millions) | Depreciation & Amortization ($ millions) | Capital Expenditures ($ millions) |
|---|---|---|---|---|---|---|---|---|
| Beauty | $16,023 | 18.41% | $2,672 | 16.53% | $6,397 | $6,152 | $410 | $415 |
| Grooming | $6,918 | 7.95% | $1,529 | 9.46% | $2,845 | $2,111 | $320 | $540 |
| Health Care | $12,456 | 14.31% | $2,404 | 14.87% | $5,208 | $4,087 | $439 | $592 |
| Fabric & Home Care | $30,314 | 34.83% | $5,632 | 34.84% | $16,428 | $6,597 | $756 | $1,250 |
| Baby, Feminine & Family Care | $20,401 | 23.44% | $3,930 | 24.31% | $11,089 | $4,167 | $835 | $1,520 |
| Corporate | $919 | 1.06% | $(23) | N/A | $1,395 | $808 | $400 | $93 |
| Total Consolidated Company | $87,032 | 100.00% | $16,144 | 100.00% | $43,362 | $23,922 | $3,160 | $4,409 |
(1) Percentage share of segment net earnings excludes Corporate results as disclosed in the segment table footnotes.
Operating margin dynamics across divisions were influenced by targeted productivity programs that yielded 180 basis points of manufacturing savings and 160 basis points of SG&A operational cost efficiencies. These improvements were offset across divisions by deliberate reinvestment into media marketing, elevated commodity input costs, and severance restructuring liabilities funded via Corporate.
The Global Product Catalog
The company focuses entirely on daily-use consumer segments differentiated into eleven specialized operating sub-categories. The commercial portfolio emphasizes non-discretionary consumer routines, insulating operational performance from broader macroeconomic fluctuations.
| Operating Segment / Category | Primary Sub-Categories Included | Fiscal 2026 % of Consolidated Sales (1) | Fiscal 2025 % of Consolidated Sales (1) | Fiscal 2024 % of Consolidated Sales (1) |
|---|---|---|---|---|
| Fabric Care | Laundry detergents, additives, fabric enhancers | 23% | 23% | 24% |
| Home Care | Dishwashing liquids, surface cleaners, air fresheners, professional | 12% | 13% | 12% |
| Baby Care | Baby wipes, taped diapers, pants | 9% | 9% | 9% |
| Hair Care | Conditioners, shampoos, styling aids, treatments | 9% | 9% | 9% |
| Family Care | Paper towels, bath tissues, facial tissues | 8% | 9% | 9% |
| Grooming | Male & female blades and razors, appliances, shave pre/post | 8% | 8% | 8% |
| Oral Care | Toothbrushes, toothpastes, rinse, accessories | 8% | 8% | 8% |
| Feminine Care | Menstrual pads and tampons, adult incontinence liners and underwear | 7% | 6% | 6% |
| Personal Health Care | Respiratory treatments, digestive wellness, analgesics, supplements | 6% | 6% | 6% |
| Personal Care | Antiperspirants and deodorants, personal cleansing bars and washes | 6% | 6% | 5% |
| Skin Care | Facial moisturizers, serums, cleansers, treatments | 4% | 3% | 4% |
(1) Segment percentage breakdown excludes net sales recorded within Corporate. Effective July 1, 2024, Skin Care and Personal Care were formally disaggregated into separate operating segments.
The Names You Know
P&G maintains proprietary global equity in iconic consumer brands supported by international patents covering formulation chemistry, industrial packaging, and automated manufacturing processes. The company holds leadership market shares across major product lines.
- Fabric & Home Care: Over 35% global market share in fabric care led by Tide, Ariel, Downy, and Gain. Global home care share exceeds 30% behind Dawn, Fairy, Cascade, Febreze, Swiffer, and Mr. Clean.
- Grooming: Over 50% share of the global grooming market. The company commands more than 60% worldwide share in blades and razors through Gillette and Venus, and nearly 30% share of male electric shavers through Braun.
- Baby, Feminine & Family Care: Commands more than 30% global market share in baby care via Pampers and Luvs. In feminine care, P&G leads globally with nearly 30% total share, including nearly 35% share in menstrual care behind Always and Tampax, and over 15% share in adult incontinence through Always Discreet. In North American family care, Bounty commands nearly 40% share of paper towels and Charmin holds over 25% share of toilet paper.
- Health Care: Nearly 30% worldwide share in oral care through Crest and Oral-B. Holds leadership positions in personal health care behind Vicks, Metamucil, Pepto-Bismol, and Neurobion.
- Beauty: Approximately 20% worldwide share in retail hair care led by Head & Shoulders, Pantene, Herbal Essences, and Rejoice. In personal care, holds the number two global position at about 20% share with Old Spice, Secret, Native, and Safeguard. In facial skin care, Olay holds roughly 5% worldwide share, complemented by super-premium skincare line SK-II.
Mapping the Global Reach
While the business distributes product across roughly 180 countries, geographic revenue disclosure reflects strong North American concentration, balanced by substantial international operations across Focus Markets and Enterprise Markets. The United States represents the single largest national market, contributing 48% of total consolidated sales.
International markets collectively account for 52% of consolidated net sales. The company’s largest individual international markets comprise Greater China, the United Kingdom, Canada, Japan, and Germany, which together represented approximately 21% of consolidated net sales in fiscal 2026.
| Geographic Market | Fiscal 2026 Net Sales ($ billions) | Fiscal 2025 Net Sales ($ billions) | Fiscal 2024 Net Sales ($ billions) | Fiscal 2026 PP&E, Net ($ billions) | Fiscal 2025 PP&E, Net ($ billions) | Sales YoY (%) |
|---|---|---|---|---|---|---|
| United States | $41.7 | $41.6 | $40.5 | $13.9 | $12.6 | +0.24% |
| International | $45.3 | $42.7 | $43.5 | $11.5 | $11.3 | +6.09% |
| Total Consolidated | $87.0 | $84.3 | $84.0 | $25.4 | $23.9 | +3.20% |
Sales to Walmart Inc. and its corporate affiliates represented approximately 16% of consolidated net sales in fiscal years 2026, 2025, and 2024. No other individual customer accounted for more than 10% of total sales. The top ten commercial customers combined accounted for approximately 43% of total net sales in 2026 and 2025, and 42% in 2024.
The Brick & Mortar Footprint
The company maintains a global real estate and industrial asset base consisting of 96 owned and operated manufacturing locations. In the United States, P&G operates 24 manufacturing sites situated in 18 states. Across international jurisdictions, the company owns and operates 72 manufacturing facilities located in 31 countries.
Production facilities are frequently multi-functional, supporting cross-divisional manufacturing. Beauty products are produced at 20 locations; Grooming at 17 locations; Health Care at 19 locations; Fabric & Home Care at 34 locations; and Baby, Feminine & Family Care at 32 locations. P&G owns its worldwide corporate headquarters complex in Cincinnati, Ohio, and maintains owned or leased regional administrative general offices in Switzerland, Panama, Singapore, China, and the United Arab Emirates, alongside shared service processing centers in Costa Rica, the United Kingdom, and the Philippines.
📊 The Financial Health: The Global Numbers Simplified
Earnings, Expenses, & Take-Home Profits
During the fiscal year ended June 30, 2026, consolidated net sales rose 3% to $87,032 million. Operating income contracted 3% to $19,748 million due to a 100-basis-point reduction in gross margin and increased strategic marketing outlays, which pushed selling, general, and administrative expenses up to 27.5% of net sales.
Net earnings attributable to Procter & Gamble rose to $16,046 million, and diluted net earnings per common share increased 2% to $6.62. Core earnings per share, which adjusts for non-core restructuring charges and the gain from the Glad joint venture dissolution, totaled $6.89.
| Consolidated Statements of Earnings ($ millions, except per share amounts) | Fiscal Year Ended June 30, 2026 | Fiscal Year Ended June 30, 2025 | Fiscal Year Ended June 30, 2024 | Latest YoY (%) |
|---|---|---|---|---|
| NET SALES | $87,032 | $84,284 | $84,039 | +3.26% |
| Cost of products sold | $43,362 | $41,164 | $40,848 | +5.34% |
| Selling, general and administrative expense | $23,922 | $22,669 | $23,305 | +5.53% |
| Indefinite-lived intangible asset impairment charge | $0 | $0 | $1,341 | N/M |
| OPERATING INCOME | $19,748 | $20,451 | $18,545 | -3.44% |
| Interest expense | $(877) | $(907) | $(925) | -3.31% |
| Interest income | $430 | $469 | $473 | -8.32% |
| Other non-operating income/(expense), net | $1,076 | $154 | $668 | +598.70% |
| EARNINGS BEFORE INCOME TAXES | $20,377 | $20,167 | $18,761 | +1.04% |
| Income taxes | $4,233 | $4,102 | $3,787 | +3.19% |
| NET EARNINGS | $16,144 | $16,065 | $14,974 | +0.49% |
| Less: Net earnings attributable to noncontrolling interests | $98 | $91 | $95 | +7.69% |
| NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | $16,046 | $15,974 | $14,879 | +0.45% |
| Basic Net Earnings Per Common Share | $6.75 | $6.67 | $6.18 | +1.20% |
| Diluted Net Earnings Per Common Share | $6.62 | $6.51 | $6.02 | +1.69% |
| Basic Weighted Average Common Shares Outstanding (millions) | 2,333.7 | 2,350.1 | 2,360.1 | -0.70% |
| Diluted Weighted Average Common Shares Outstanding (millions) | 2,422.5 | 2,454.4 | 2,471.9 | -1.30% |
Gross margin compression of 100 basis points to 50.2% reflected unfavorable product mix headwinds (120 bps), product and packaging investments (70 bps), restructuring outlays (60 bps), commodity cost inflation (20 bps), and foreign exchange movements, offset by 180 basis points of internal manufacturing productivity cost savings and 40 basis points of pricing realization.
Assets, Debts, & Corporate Wealth
As of June 30, 2026, total assets rose to $126,521 million from $125,231 million in 2025. Total liabilities declined to $72,210 million, generating total shareholders’ equity of $54,311 million.
Working capital remained negative, with current liabilities of $38,694 million exceeding current assets of $26,208 million by $12,486 million. This profile reflects extensive reliance on short-term supplier trade payables ($16,306 million) and commercial paper credit markets ($4,837 million) to fund ongoing operational cycles.
| Consolidated Balance Sheets ($ millions, as of June 30) | 2026 | 2025 | Latest YoY (%) |
|---|---|---|---|
| Cash and cash equivalents | $9,942 | $9,556 | +4.04% |
| Accounts receivable | $6,056 | $6,185 | -2.09% |
| Materials and supplies | $2,143 | $2,022 | +5.98% |
| Work in process | $1,105 | $1,012 | +9.19% |
| Finished goods | $4,922 | $4,516 | +8.99% |
| Total inventories | $8,170 | $7,551 | +8.20% |
| Prepaid expenses and other current assets | $2,040 | $2,100 | -2.86% |
| TOTAL CURRENT ASSETS | $26,208 | $25,392 | +3.21% |
| Property, plant and equipment, gross | $57,172 | $54,181 | +5.52% |
| Accumulated depreciation | $(31,811) | $(30,284) | +5.04% |
| PROPERTY, PLANT AND EQUIPMENT, NET | $25,360 | $23,897 | +6.12% |
| Goodwill | $41,276 | $41,650 | -0.90% |
| Trademarks and other intangible assets, net | $21,444 | $21,910 | -2.13% |
| Other noncurrent assets | $12,231 | $12,381 | -1.21% |
| TOTAL ASSETS | $126,521 | $125,231 | +1.03% |
| Accounts payable | $16,306 | $15,227 | +7.09% |
| Accrued and other liabilities | $11,091 | $11,318 | -2.01% |
| Debt due within one year | $11,296 | $9,513 | +18.74% |
| TOTAL CURRENT LIABILITIES | $38,694 | $36,058 | +7.31% |
| Long-term debt | $22,842 | $24,995 | -8.61% |
| Deferred income taxes | $5,760 | $5,774 | -0.24% |
| Other noncurrent liabilities | $4,914 | $6,120 | -19.71% |
| TOTAL LIABILITIES | $72,210 | $72,946 | -1.01% |
| Convertible Class A preferred stock | $756 | $777 | -2.70% |
| Non-Voting Class B preferred stock | $0 | $0 | N/M |
| Common stock | $4,009 | $4,009 | 0.00% |
| Additional paid-in capital | $69,533 | $68,770 | +1.11% |
| Reserve for ESOP debt retirement | $(596) | $(672) | -11.31% |
| Accumulated other comprehensive loss | $(12,465) | $(12,143) | +2.65% |
| Treasury stock | $(143,008) | $(138,702) | +3.10% |
| Retained earnings | $135,852 | $129,973 | +4.52% |
| Noncontrolling interest | $230 | $272 | -15.44% |
| TOTAL SHAREHOLDERS’ EQUITY | $54,311 | $52,284 | +3.88% |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $126,521 | $125,231 | +1.03% |
Cash Flow: Tracking the Money Movement
Net cash provided by operating activities totaled $19,556 million in fiscal 2026, an expansion of 10% compared to $17,817 million in fiscal 2025. Growth was driven by stable operating earnings, working capital optimization, and a $919 million cash benefit from extended accounts payable settlement timings.
Investing cash activities absorbed $4,624 million, driven by capital additions of $4,409 million and net derivative hedge settlements, offset by $508 million in asset sale proceeds. Financing outflows totaled $14,460 million, primarily directed toward returning capital through common and preferred dividends ($10,232 million) and open-market share buybacks ($5,028 million).
| Consolidated Statements of Cash Flows ($ millions, fiscal years ended June 30) | 2026 | 2025 | 2024 | Latest YoY (%) |
|---|---|---|---|---|
| Cash, Cash Equivalents & Restricted Cash, Beginning | $9,556 | $9,482 | $8,246 | +0.78% |
| OPERATING ACTIVITIES | ||||
| Net earnings | $16,144 | $16,065 | $14,974 | +0.49% |
| Depreciation and amortization | $3,160 | $2,847 | $2,896 | +10.99% |
| Share-based compensation expense | $524 | $476 | $562 | +10.08% |
| Deferred income taxes | $51 | $149 | $(244) | -65.77% |
| (Gain)/loss on sale of assets | $(351) | $755 | $(215) | N/M |
| Indefinite-lived intangible asset impairment charge | $0 | $0 | $1,341 | N/M |
| Change in accounts receivable | $84 | $45 | $(766) | +86.67% |
| Change in inventories | $(641) | $(324) | $(70) | +97.84% |
| Change in accounts payable | $919 | $(542) | $878 | N/M |
| Other operating activities | $(333) | $(1,653) | $491 | -79.85% |
| TOTAL OPERATING ACTIVITIES | $19,556 | $17,817 | $19,846 | +9.76% |
| INVESTING ACTIVITIES | ||||
| Capital expenditures | $(4,409) | $(3,773) | $(3,322) | +16.86% |
| Proceeds from asset sales | $508 | $107 | $346 | +374.77% |
| Acquisitions, net of cash acquired | $(85) | $(11) | $(21) | +672.73% |
| Other investing activity | $(638) | $(141) | $(507) | +352.48% |
| TOTAL INVESTING ACTIVITIES | $(4,624) | $(3,818) | $(3,504) | +21.11% |
| FINANCING ACTIVITIES | ||||
| Dividends to shareholders | $(10,232) | $(9,872) | $(9,312) | +3.65% |
| Additions to short-term debt (maturities > 3 months) | $7,941 | $8,020 | $3,528 | -0.99% |
| Reductions in short-term debt (maturities > 3 months) | $(9,984) | $(6,512) | $(7,689) | +53.32% |
| Net additions/(reductions) to other short-term debt | $2,674 | $(1,138) | $857 | N/M |
| Additions to long-term debt | $2,652 | $2,237 | $3,197 | +18.55% |
| Reductions in long-term debt | $(3,390) | $(1,977) | $(2,335) | +71.47% |
| Treasury stock purchases | $(5,028) | $(6,500) | $(5,006) | -22.65% |
| Impact of stock options and other | $907 | $1,707 | $1,905 | -46.87% |
| TOTAL FINANCING ACTIVITIES | $(14,460) | $(14,036) | $(14,855) | +3.02% |
| Effect of Exchange Rate Changes | $(86) | $112 | $(251) | N/M |
| Change in Cash, Cash Equivalents & Restricted Cash | $386 | $75 | $1,235 | +414.67% |
| CASH, CASH EQUIVALENTS & RESTRICTED CASH, END | $9,942 | $9,556 | $9,482 | +4.04% |
Funding the Future: R&D and Expansion Spending
To support its brand superiority strategy, P&G allocated $2,100 million to internal research and development activities in fiscal 2026, identical to the $2,100 million spent in 2025 and up from $2,000 million in 2024. Advertising expenditures charged directly to SG&A expanded to $10,200 million in 2026, compared to $9,200 million in 2025 and $9,600 million in 2024.
The company maintains binding contractual purchase obligations and capital investment commitments designed to preserve supply security and infrastructure reliability. Total recorded liabilities and off-balance sheet contractual purchase commitments totaled $45,843 million as of June 30, 2026.
| Contractual Commitments ($ millions) | Total Amount Due | Less Than 1 Year | 1–3 Years | 3–5 Years | After 5 Years |
|---|---|---|---|---|---|
| Total debt principal | $34,490 | $11,357 | $4,173 | $6,306 | $12,654 |
| Operating leases | $1,028 | $246 | $376 | $208 | $198 |
| Interest payments relating to long-term debt | $6,102 | $884 | $1,365 | $1,075 | $2,777 |
| Minimum pension statutory funding | $573 | $186 | $387 | $0 | $0 |
| Purchase obligations (take-or-pay) | $3,651 | $1,155 | $1,366 | $636 | $494 |
| TOTAL CONTRACTUAL COMMITMENTS | $45,843 | $13,828 | $7,667 | $8,225 | $16,123 |
🗺️ The Corporate Family Tree: Structure & Investments
Subsidiaries, Associates, & Shared Ventures
The Procter & Gamble Company operates globally through hundreds of integrated direct and indirect operating subsidiaries. Significant operational legal entities specifically highlighted in regulatory proceedings include Procter & Gamble UK (P&G UK), a wholly owned operating subsidiary based in the United Kingdom managing domestic production facilities including a major London-based manufacturing site.
In January 2026, the long-standing Glad joint venture agreement between P&G and The Clorox Company reached contractual expiration. Under the terms of the governing pact, Clorox acquired P&G’s minority equity interest in the venture at fair market value for $476 million in cash consideration, resulting in the formal dissolution of the joint venture business and a recognized after-tax divestiture gain of $261 million ($343 million before tax).
- Glad Joint Venture Dissolution: Expiration of the collaborative venture in January 2026 yielded $476 million in proceeds and an after-tax accounting gain of $261 million.
- Procter & Gamble UK: Key wholly owned subsidiary operating principal manufacturing facilities in the United Kingdom.
Strategic Investments & Minority Stakes
The company maintains minor non-controlled equity method holdings and financial equity investments in external commercial entities that support core distribution and regional formulation processing. Equity investments lacking readily determinable market values are measured at cost minus impairment, plus observable price adjustments, and are categorized within Other noncurrent assets on the balance sheet.
On August 4, 2026, the company entered into a definitive merger agreement to acquire Thorne, an external premium wellness and supplement brand operating in the vitamins, minerals, and supplements (VMS) category, for total cash consideration of $3.8 billion. The acquisition is anticipated to close in the second quarter of fiscal year 2027 subject to customary regulatory clearances.
👥 Power & Control: Who Pulls the Strings?
The Brain Trust: Board of Directors & Executive Leadership
Corporate governance is administered by the Board of Directors, which includes designated independent financial experts serving on the Audit Committee: Mr. Brett Biggs and Ms. Christine McCarthy (Chair). Management of the enterprise is executed by a senior executive leadership team possessing extensive tenure within the corporation.
| Executive Officer Shailesh G. Jejurikar | Age 59 | Corporate Position Held (as of August 4, 2026) Chairman of the Board, President and Chief Executive Officer | First Elected Officer 2018 | Prior Corporate Roles Disclosed Chief Operating Officer (2021–2025); CEO – Fabric and Home Care (2019–2021) | Latest YoY (%) |
|---|---|---|---|---|---|
| Andre Schulten | 55 | Chief Financial Officer | 2021 | Senior Vice President – Baby Care North America and corporate finance leadership roles | – |
| Hesham Tohamy Abd El Hak | 51 | Chief Executive Officer – Baby and Feminine Care | 2026 | President – Baby Care (2026); President – Feminine Care (2022–2025) | – |
| Juliana Azevedo | 50 | Chief Executive Officer – Grooming | 2026 | President – Home Care & P&G Professional (2024–2026); President – Latin America (2022–2024) | – |
| Freddy Bharucha | 54 | Chief Executive Officer – Beauty | 2025 | President – Personal Care and North America Beauty (2023–2025); SVP Personal Care NA (2018–2023) | – |
| Paul Gama | 60 | Chief Executive Officer – Health Care | 2026 | President – Personal Health Care (2020–2026) | – |
| Sundar G. Raman | 51 | CEO – Fabric & Home Care, Exec. Sponsor Corporate Sustainability | 2021 | President – Fabric Care; leadership positions across global home care franchises | – |
| Victor Aguilar | 59 | Chief Research, Development and Innovation Officer | 2020 | Vice President – Corporate Research & Development across multiple sector categories | – |
| Marc S. Pritchard | 66 | Chief Brand Officer | 2008 | President – Global Strategy; Global Marketing and Brand leadership | – |
| Balaji Purushothaman | 57 | Chief Human Resources Officer | 2023 | Senior Vice President – HR, Global Total Rewards and Employee Relations (2020–2022) | – |
| Susan Street Whaley | 52 | Chief Legal Officer and Secretary | 2022 | Senior Vice President and General Counsel – North America (2019–2022) | – |
All executive officers listed have completed more than five years of continuous service within the company, reflecting P&G’s internal develop-from-within executive succession and talent retention architecture.
Who Owns the Stock?
The company maintains a broad retail and institutional ownership base, with approximately 6 million common stock shareowners of record, plan participants, and beneficial owners as of June 30, 2026. A total of 2,324,433,060 shares of Common Stock were outstanding as of July 31, 2026.
Employee stock ownership represents an important internal equity component. P&G maintains an Employee Stock Ownership Plan (ESOP) within The Procter & Gamble Profit Sharing Trust. The Trust holds allocated Series A Preferred Shares (18 million shares outstanding) and Series B Preferred Shares (48,642 thousand shares outstanding, comprising 36,365 thousand allocated and 12,277 thousand unallocated shares), which are convertible on a one-for-one basis into common shares and fund postretirement healthcare benefits.
| Equity Compensation Plan Category (as of June 30, 2026) | Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants, Rights (a) | Weighted Average Exercise Price of Outstanding Options, Warrants, Rights (b) | Number of Securities Remaining Available for Future Issuance Under Plans (c) |
|---|---|---|---|
| Stock Options / Stock Appreciation Rights | 94,554,254 | $127.0740 | (1) |
| Restricted Stock Units (RSUs) & Performance Stock Units (PSUs) | 6,699,124 | N/A | (1) |
| Total Approved Equity Plans | 101,253,378 | $127.0740 | 213,000,000 |
(1) Future equity issuances are authorized solely under the shareholder-approved 2025 Stock and Incentive Compensation Plan. Under plan rules, stock options and SARs count on a one-for-one basis, whereas full-value awards (RSUs and PSUs) reduce the pool by five shares for each unit awarded.
🎯 The Strategic Outlook: Future Plans & Potential Pitfalls
Competitive Advantages & Economic Moats
P&G’s structural economic moat is underpinned by continuous reinvestment into five integrated choices: a daily-use product portfolio where performance determines brand selection; product, packaging, and commercial execution superiority; ongoing structural productivity; constructive industry disruption; and an agile organizational design.
The company operates extensive manufacturing scale, with $25.4 billion in net PP&E and centralized supplier finance programs managing over $6.1 billion in confirmed obligations. This scale allows P&G to negotiate advantageous payment terms ranging from 60 to 180 days with vendors, securing working capital efficiencies that smaller, regional consumer packaged goods competitors cannot replicate.
- Intangible Brand Assets: $21,444 million in total net trademarks and other intangible assets (including $19,535 million in indefinite-lived brand trademarks and $1,909 million in amortizable intangible assets) alongside $41,276 million in consolidated goodwill.
- Internal Productivity Engine: Annualized cost reduction initiatives generated 180 basis points of gross manufacturing savings and 160 basis points of SG&A operational efficiency during fiscal 2026.
- Massive Marketing Scale: Direct annual advertising expenditures of $10,200 million reinforce global brand awareness and support retail distribution pricing tiers.
- Shareholder Distribution History: Continuous dividend payments for 136 consecutive years since incorporation in 1890, alongside annual dividend increases for 70 consecutive years.
What Could Go Wrong? Key Challenges & Business Risks
The enterprise faces operational, legal, geopolitical, and macroeconomic risks arising from its international manufacturing and commercial footprint.
- Foreign Currency Exchange Devaluation: Because more than 50% of annual net sales are generated outside the United States, foreign currency fluctuations against the U.S. dollar, particularly the Euro, directly impact reported earnings, cash repatriation capabilities, and derivative net investment hedge settlements.
- Gillette Brand Impairment Sensitivity: The Gillette indefinite-lived intangible asset carries a book value of $12.8 billion (following an earlier $1.3 billion pre-tax impairment charge in 2024). Sensitivity modeling reveals that a 25-basis-point increase in the discount rate or a 25-basis-point decrease in projected growth rates would reduce fair value by approximately 5%, while a 50-basis-point decrease in the royalty rate would reduce fair value by 4%.
- Geopolitical & Sanctions Disruptions: Ongoing military hostilities in the Middle East and between Russia and Ukraine present supply chain and energy price volatility. P&G’s Russian operations account for 1% of consolidated net sales, net earnings, and net assets as of June 30, 2026, and remain exposed to potential asset write-downs, operational discontinuation, or deconsolidation.
- Customer Concentration Exposure: Net sales to Walmart Inc. and its affiliates represent 16% of total company sales, while the top ten retail customers comprise 43% of total net sales. Negotiations regarding merchandising funds, inventory stocking levels, shelf space allocation, or order windows carry material financial exposure.
- Regulatory & Environmental Inquiries: In July 2025, the U.K. Environment Agency formally notified P&G UK of its intent to impose a civil penalty of less than $2 million concerning historical permitting documentation for greenhouse gas emissions at its London production facility.
- Commodity Price Inflation & Supply Chain Vulnerability: Heavy structural exposure to pulp, petroleum-derived resins, transportation freight costs, and single-source packaging suppliers introduces cost pressures that require continuous pricing increases and productivity offsetting.
The Next Chapter: Growth & Expansion Initiatives
In June 2025, management initiated a comprehensive two-year portfolio, supply chain, and productivity plan designed to streamline corporate overhead and optimize manufacturing assets. The company expects to incur between $1.5 billion and $2.0 billion in total pre-tax restructuring charges across fiscal 2026 and 2027, of which $1.2 billion was recorded in fiscal 2026.
The productivity initiative encompasses a planned structural reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027, along with targeted brand exits, plant consolidations, and accelerated depreciation write-downs. These structural cost savings are designed to fund digital marketing tools, artificial intelligence integration across supply chains, and external strategic brand acquisitions, including the pending $3.8 billion purchase of Thorne in fiscal 2027.
The Verdict: Strategic Outlook & Conclusion
The Procter & Gamble Company closed fiscal year 2026 with $87,032 million in consolidated net sales, $16,046 million in net earnings attributable to the enterprise, and $19,556 million in operating cash flows. The company’s focus on daily-use consumer segments, coupled with productivity programs delivering over 340 basis points of combined operational margin improvements, provided resilience against cost inflation and foreign currency headwinds.
Management’s balanced deployment of capital—returning $15,260 million to shareholders through dividends and share repurchases, maintaining adjusted free cash flow productivity at 100%, and optimizing non-manufacturing overhead through its restructuring program—positions P&G to support its long-term financial algorithm of mid-to-high single-digit Core EPS growth and top-third shareholder value creation.
Official Site: https://www.pginvestor.com
Note: Financial ratios, margins, year-over-year (YoY) growth rates, and percentage shares of revenue are calculated by FirmsWorld based on figures reported in the company’s official SEC filing.